TUCATINIB

Tucatinib

Empowering Breast Cancer Treatment

Molecular Name: Tucatinib

Active Ingredient: Tucatinib

Strength: Tucatinib is available in tablets containing 50 mg, 150 mg, and 200 mg of tucatinib

Manufacturer Name:

List of Excipients
Tablet core:
1.Lactose monohydrate
2.Microcrystalline cellulose
3.Croscarmellose sodium
4.Magnesium stearate
Film-coating:
1.Hypromellose
2.Titanium dioxide (E171)
3.Triacetin


Tucatinib is a breakthrough medication designed to address the treatment of locally advanced or metastatic breast cancer, particularly in cases where the cancer is HER2-positive. This advanced therapy offers hope and efficacy for individuals facing these challenging circumstances, providing a new avenue for improving quality of life and extending survival rates.

Special Storage Precautions: Tucatinib tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F). The tablets should be protected from light and moisture. It’s important to follow the storage instructions provided by the manufacturer and your healthcare provider.

Key Features:
Innovative Treatment: Tucatinib presents a cutting-edge approach to battling HER2-positive breast cancer, offering patients a new perspective on managing their condition.
Targeted Approach: Designed specifically for cases of locally advanced or metastatic breast cancer that are HER2-positive, Tucatinib focuses on combating the underlying causes of the disease.
Enhanced Survival Rates: Clinical trials have shown that Tucatinib can significantly extend survival rates and improve overall prognosis in eligible patients.
Expert Backing: Tucatinib is backed by extensive research and development, ensuring a high standard of care and a potential game-changer in breast cancer treatment.
Specifications:
Form: Oral tablets
Dosage Strengths: Available in various strengths for personalized treatment plans
Packaging: Each bottle contains a one-month supply

Usage Guidelines:

Please consult your healthcare provider for specific usage guidelines tailored to your medical condition and needs. Do not alter your treatment plan without professional guidance.

Disclaimer:

It’s important to note that Tucatinib is a prescription medication and should only be used under the guidance of a qualified healthcare provider. This product page provides general information and should not be considered a substitute for medical advice. Consult with your doctor to determine if Tucatinib is a suitable treatment option for you.

FAQ’s

  1. Tucatinib may not be suitable for individuals with certain medical conditions or those taking specific medications. Consult your healthcare provider to determine if Tucatinib is safe for you.
  1. Tucatinib should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
  1. Clinical trials have demonstrated that Tucatinib can be highly effective in addressing HER2-positive breast cancer, particularly in cases that are locally advanced or metastatic. However, individual responses may vary, and it’s important to discuss your expectations and potential outcomes with your healthcare provider.
  1. Tucatinib is taken orally in the form of tablets. The specific dosage and administration schedule will be determined by your healthcare provider based on your medical history and condition.
  1. Like all medications, Tucatinib may have potential side effects. Common side effects may include nausea, vomiting, diarrhea, and fatigue. It’s crucial to discuss possible side effects with your healthcare provider and to seek medical attention if you experience any adverse reactions.